Clinical Trial Eligibility and Outcomes in Patients With Metastatic NSCLC Treated Outside of Clinical Trials
ByClayton K. Oakley, DO, MS, MA,Amulya Yellala, MD,Sunil Tulpule, MD,Robin High, MA,Apar Kishor Ganti, MD,Alissa S. Marr, MD
Published: | Updated:
These data support less restrictive clinical trial eligibility criteria for those with metastatic NSCLC. This is especially true regarding both targeted therapy and immunotherapy treatment regimens.
